Atrial natriuretic peptide relaxes arterial basal tone induced by coarctation hypertension

Peptides

Volumn 20, Issue 4, 1999, Pages 485-491

  Peral De Brunoa, M ^a   Romano, L ^a   Proto, M ^a   Coviello, A ^b  

^a UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

^b Fundacion INELCO   (Argentina)

Author keywords

Atrial natriuretic peptide; Basal tone; Hypertension; Vascular reactivity

Indexed keywords

ACETYLCHOLINE; ATRIAL NATRIURETIC FACTOR; CALCIUM; CALPHOSTIN C; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NITROPRUSSIDE SODIUM; PROTEIN KINASE C; STAUROSPORINE;

ABDOMINAL AORTA; ANIMAL TISSUE; ARTERY TONE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; HYPERTENSION; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA;

ACETYLCHOLINE; ANIMALS; AORTA, ABDOMINAL; AORTA, THORACIC; ATRIAL NATRIURETIC FACTOR; CALCIUM; ENDOTHELIUM, VASCULAR; HYPERTENSION; ISOMETRIC CONTRACTION; MALE; MUSCLE RELAXATION; MUSCLE TONUS; MUSCLE, SMOOTH, VASCULAR; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032887314     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00030-3     Document Type: Article

References (34)

1. Bell D.R., Bohr D.F. Endothelium in functional aortic changes of coarctation hypertension. Am J Physiol (Heart Circ Physiol 29). 260:1991;H1187-H1193.
2. Brenner B., Ballermann B.J., Gunning M.E., Zeidel M.L. Diverse biological actions of atrial natriuretic peptide. Physiol Rev. 70:1990;665-669.
3. Chinkers M., Garbers D.L., Chang M.S., Lowe D.G., Chin H., Goeddel D.V., Schulz S. A membrane from guanylate cyclase is an atrial natriuretic peptide receptor. Nature (London). 338:1989;78-83.
4. i. Am J Physiol. 262:1992;H754-H762.
5. Currie M.G., Geller D.M., Cole B.R., Boylan J.G., Yusheng W., Holmberg S.W., Needleman P. Bioactive cardiac substances potent vasorelaxant activity in mammalian aorta . Science. 221:1983;71-73.
6. Faber J.E. Lack of an effect of atrial natriuretic peptide on myogenic contraction of microvascular smooth muscle. Am J Physiol. 258:1990;H419-H423.
7. Faber J.E., Gettes D.R., Gianturco D.P. Microvascular effect of atrial natriuretic factor interaction with α1- and α2-adrenoceptors . Circ Res. 63:1998;415-428.
8. Fernándes M., Onesti G., Weder A., Dykyj R., Gould A.B., Kim K.E., Swartz C. Experimental model of severe renal hypertension. J Lab Clin Med. 87:1976;561-567.
9. Fiscus R.R., Rapoport R.M., Waldman S.A., Murad F. Atriopeptin II elevates cyclic GMP, activated cyclic-GMP-dependent protein kinase and causes relaxation in rat thoracic aorta. Biochim Biophys Acta. 846:1985;179-184.
10. Francis S.H., Corbin J.D. Structure and function of cyclic nucleotide-dependent protein kinases. Ann Rev Physiol. 56:1994;237-272.
11. Garcia R., Thibault G., Genest J., Cantin M. Effect of a purified atrial natriuretic factor on a rat and rabbit strips and vascular beds. Am J Physiol. 247:1984;R34-R39.
12. Gonzalez J.M., Suki W.N. Cell calcium and arterial blood pressure. Semin Nephrol. 15:1995;564-568.
13. Guyton J.R., Dao D.T., Kay L.L., Taylor A.A. Ultrastructure of hypertensive rat aorta increased basement membrane-like material . Hypertension. 15:1990;56-57.
14. G-Nitro-L-Arginine methyl ester. Hypertension. 28:1996;361-366.
15. Ignarro L.J., Wood K.S., Fukoto J.M. Continuous basal formation of endothelium derived relaxing factor and muscle derived relaxing factor both of which are nitric oxide. J Cardiovasc Pharmacol. 17:1991;229-233.
16. Jones A.W. Altered ion transport in large and small arteries from spontaneously hypertensive rats and the influence of calcium. Circ Res. 34,35(Suppl. I):1974;I117-I22.
17. Marin-Grez M., Fleming J.T., Steinhausen M. Atrial natriuretic peptide preglomerular vasodilatation and postglomerular vasoconstriction in rat kidney. Nature. 224:1986;473-476.
18. Meisheri K.D., Taylor C.J., Saneii H. Synthetic atrial peptide inhibit intracellular calcium release in smooth muscle. Am J Physiol. 250:1986;C171-C4.
19. Mulvany M.J. Do resistance vessels abnormalities contribute to the elevated blood pressure of spontaneously hypertensive rats? A review of some evidence. Blood Vessels. 20:1983;1-22.
20. Noon J.P., Rice P.J., Baldessarini R.J. Calcium leakage as a cause of the high resting tension in vascular smooth muscle from the spontaneously hypertensive rat. Proc Natl Acad Sci USA. 75:1978;1605-1607.
21. Peral de Bruno M., Coviello A., Meyer M., Forssmann W.G. Relaxation of non-contracted smooth muscle by atrial natriuretic peptide. Clin and Exper Hyper -Theory and Practice A. 14:1992;1125-1139.
22. Peral de Bruno M., Coviello A. Effects of atrial natriuretic peptide and toad heart extract on isolated toad Bufo arenarum aortic rings. Gen Comp Endocrinol. 88:1992;424-433.
23. Proctor K.G., Bealer S.L. Selective antagonism of hormone induced vasoconstriction by synthetic atrial natriuretic factor in the rat microcirculation. Circ Res. 61:1987;42-49.
24. Pucci M.L., Miller K.B., Dick L.B., Guan H., Lin L., Nasjletti A. Vascular responsiveness to nitric oxide synthesis inhibition in hypertensive rats. Hypertension. 23:1994;744-751.
25. Pucci M.L., Tong X., Miller K.B., Guan H., Lin L., Nasjletti A. Calcium- and protein kinase C-dependent basal tone in the aorta of hypertensive rats. Hypertension. 25:1995;752-757.
26. 2+-dependent tone of aorta in hypertensive rats. Hypertension. 13:1989;582-588.
27. Sato M., Abe K., Takeuchi K., Yasujima M., Omata K., Hiwatari M., Kasai Y., Tanno M., Kohzuki M., Kudo K., Yoshinaga K., Inagami T. Atrial natriuretic factor and cyclic guanosine 3′,5′ monophosphate in vascular smooth muscle. Hypertension. 8:1986;562-771.
28. Sunano S., Sekiguchi F., Takeuchi K., Shibutani S., Matsuda K., Shimamura K. Attenuation of intrinsic active tone by endothelium-derived nitric oxide in aortae of spontaneously hypertensive rats with different levels of blood pressure. Clin Exp Hypertens. 18:1996;873-890.
29. Thompson L.P., Bruner T.A., Lamb F.S., King C.M., Webb R.C. Calcium influx and vascular reactivity in systemic hypertension. Am J Cardiol. 59:1987;29A-34A.
30. Webb R.C. Vascular changes in hypertension. Antonaccio M.J. Cardiovascular pharmacology, 2nd ed. 1984;215-225 Raven Press, New York.
31. Wei ChM, Kim ChH, Khraibi A.A., Miller V.M., Burnett J.M. Jr. Atrial natriuretic peptide and C-type natriuretic peptide in spontaneously hypertensive rats and their vasorelaxing actions in vitro. Hypertension. 23:(part 2):1994;903-907.
32. Winquist R.J., Faison E.P., Nutt R.F. Vasodilator profile of synthetic atrial natriuretic factor. Eur J Pharmacol. 102:1984;169-173.
33. Winquist R.J., Faison E.P., Waldman S.A., Schwartz K., Murad F., Rapoport R.M. Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevated cyclic GMP in rat tissues. J Biol Chem. 259:1984;14332-14334.
34. Zhou H.L., Fiscus R.R. Brain natriuretic peptide (BNP) causes endothelium-independent relaxation and elevation of cyclic GMP in rat thoracic aorta. Neuropeptide. 14:1989;161-169.